Smoking Cessation Intervention for Lung Cancer Prevention

This trial aims to reduce lung cancer among African American smokers by combining lung cancer screening with a smoking cessation multilevel intervention. Researchers are examining how these two approaches can work together to enhance health outcomes. The trial includes one group receiving low-dose CT scans for lung cancer screening and another group without any intervention. It suits African Americans who have smoked for 20 or more years, are current smokers, and either have been screened for lung cancer or are eligible for screening. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could significantly improve health outcomes for African American smokers.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that combining smoking cessation programs with lung cancer screening is effective and generally safe. Studies have found that participants in these programs are much more likely to quit smoking than those who do not participate. For instance, one study found that these programs increased quit rates by about 36%. This suggests that participants find the programs easy to follow, as higher quit rates often indicate adherence without major issues.

Researchers are excited about this trial because it combines a smoking cessation intervention with low-dose CT (LDCT) lung cancer screening, which is a unique approach for lung cancer prevention. Unlike traditional methods that focus solely on smoking cessation through counseling or medications like nicotine replacement therapy, this approach integrates early detection of potential lung abnormalities. The LDCT screening aims to catch lung issues earlier than usual, providing an extra layer of prevention. This dual strategy could significantly enhance the ability to prevent lung cancer in high-risk individuals by addressing both smoking habits and early lung health monitoring.

Research has shown that quitting smoking can significantly improve survival chances for people with lung cancer. A review of 25 studies involving over 17,000 people found that those who stopped smoking at diagnosis had a 26% lower risk of dying. In this trial, participants may receive a smoking cessation multilevel intervention, proven to increase success rates by 36% compared to no support. Additionally, combining smoking cessation with lung cancer screening, as tested in this trial, can reduce lung cancer cases and save more lives. Quit rates of 14.3% after three months and 10.3% after six months have been observed, indicating significant progress for those attempting to quit.¹²³⁵⁶